Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis

被引:654
作者
Pulte, Dianne [1 ,2 ]
Brenner, Hermann [2 ]
机构
[1] Univ Med & Dent New Jersey, Div Hematol Oncol, Dept Med, Newark, NJ 07101 USA
[2] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany
关键词
Head and neck cancer; Epidemiology; Survival; Period analysis; Population analysis; SQUAMOUS-CELL CARCINOMA; UP-TO-DATE; RANDOMIZED-TRIAL; HUMAN-PAPILLOMAVIRUS; RADIATION-THERAPY; PATIENT SURVIVAL; UNITED-STATES; STAGE-III; CHEMOTHERAPY; RADIOTHERAPY;
D O I
10.1634/theoncologist.2009-0289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Therapy for head and neck cancers has evolved over the past decade, but few detailed analyses of recent developments in survival on the population level have been published. Methods. We use period analysis and modeled period analysis to disclose recent trends in survival in patients with head and neck cancer. Data are derived from the Surveillance, Epidemiology, and End Results limited-use database. Results. A major, statistically significant improvement in survival was observed, with the overall 5-year relative survival rate going from 54.7% in 1992-1996 to 65.9% in 2002-2006. Subgroup analysis showed improvement in cancers of the oral cavity, tongue, tonsils, and nasopharynx, with the greatest improvements observed in tonsillar carcinoma (+22.2 percentage points) and carcinoma of the tongue (+14.4 percentage points). Further analysis of survival for oral cavity, tonsillar, and tongue carcinoma revealed improvements in survival at each stage and across all age groups except for patients aged >= 75 years, with the greatest improvement occurring in locally advanced disease and in patients aged 55-64 years for carcinoma of the tongue and tonsils and those aged 15-44 years for oral cavity cancers. Conclusions. Survival has substantially improved for head and neck cancer patients over the past decade. The greatest improvement was seen in tonsillar and tongue cancers. The Oncologist 2010;15:994-1001
引用
收藏
页码:994 / 1001
页数:8
相关论文
共 24 条
[1]  
Adelstein DJ, 1997, HEAD NECK-J SCI SPEC, V19, P567, DOI 10.1002/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.3.CO
[2]  
2-N
[3]  
Adelstein DJ, 2000, CANCER, V88, P876, DOI 10.1002/(SICI)1097-0142(20000215)88:4<876::AID-CNCR19>3.0.CO
[4]  
2-Y
[5]   Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].
Al-Sarraf, M ;
LeBlanc, M ;
Giri, PGS ;
Fu, KK ;
Cooper, J ;
Vuong, T ;
Forastiere, AA ;
Adams, G ;
Sakr, WA ;
Schuller, DE ;
Ensley, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317
[6]  
Arias Elizabeth, 2002, Natl Vital Stat Rep, V51, P1
[7]   Use of period analysis for providing more up-to-date estimates of long-term survival rates:: empirical evaluation among 370 000 cancer patients in Finland [J].
Brenner, H ;
Söderman, B ;
Hakulinen, T .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (02) :456-462
[8]   Up-to-date long-term survival curves of patients with cancer by period analysis [J].
Brenner, H ;
Hakulinen, T .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :826-832
[9]  
Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO
[10]  
2-#